Company intelligence / Profile preview

HeartPoint Global

Coral Gables, Florida, United Statesheartpointglobal.com ↗

Ownership: Private
Development stage: Preclinical

Overview

HeartPoint Global has demonstrated successful pre-clinical results with its patented minimally invasive implant system. The device can be placed in the main pulmonary artery or its branches and allows for post-placement adjustment of blood flow. Pre-clinical studies have shown that it can treat both right-sided and left-sided heart diseases by modulating cardiac structure/function. Clinical trials are expected to begin soon in Europe.

Therapeutic areas: Cardiovascular
Modalities: DeviceStent-based therapy (specifically self-expanding nitinol stents)Minimally invasive intervention/device therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on HeartPoint Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartPoint Global.

Explore the full profile